These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 85869)

  • 1. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
    Papapoulos SE; Clemens TL; Fraher LJ; Lewin IG; Sandler LM; O'Riordan JL
    Lancet; 1979 Mar; 1(8117):627-30. PubMed ID: 85869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
    Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
    J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
    Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
    J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
    Frame B; Parfitt AM
    Ann Intern Med; 1980 Sep; 93(3):449-51. PubMed ID: 7436165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
    Barbour GL; Coburn JW; Slatopolsky E; Norman AW; Horst RL
    N Engl J Med; 1981 Aug; 305(8):440-3. PubMed ID: 6894783
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
    Stern PH; De Olazabal J; Bell NH
    J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of circulating 25,26-dihydroxycholecalciferol in man by radioimmunoassay.
    Fraher LJ; Clemens TL; Papapoulos SE; Redel J; O'Riordan JL
    Clin Sci (Lond); 1980 Oct; 59(4):257-63. PubMed ID: 7428293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy.
    Chesney RW; Hamstra AJ; DeLuca HF; Horowitz S; Gilbert EF; Hong R; Borcherding W
    J Pediatr; 1981 Jun; 98(6):919-22. PubMed ID: 7229793
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
    Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
    Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D metabolites in idiopathic infantile hypercalcaemia.
    Martin ND; Snodgrass GJ; Cohen RD; Porteous CE; Coldwell RD; Trafford DJ; Makin HL
    Arch Dis Child; 1985 Dec; 60(12):1140-3. PubMed ID: 3879160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absence of 24,25-dihydroxycholecalciferol in anephric patients.
    Taylor CM; Mawer EB; Wallace JE; St John J; Cochran M; Russell RG; Kanis JA
    Clin Sci Mol Med Suppl; 1978 Dec; 55(6):541-7. PubMed ID: 216522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
    Gibbs CJ; Peacock M
    Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxycholecalciferol in pathogenesis of hypercalcaemic sarcoidosis.
    MacGregor GA
    Lancet; 1979 May; 1(8124):1041. PubMed ID: 86767
    [No Abstract]   [Full Text] [Related]  

  • 16. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects.
    Juttmann JR; Visser TJ; Buurman C; de Kam E; Birkenhäger JC
    Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1349-52. PubMed ID: 6786491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
    Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia with elevated dihydroxycholecalciferol levels and hypercalciuria. A parathyroid concentration-independent mechanism.
    Silver J; Popovtzer MM
    Arch Intern Med; 1984 Jan; 144(1):162-3. PubMed ID: 6691752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tubular maximum for calcium reabsorption in patients with chronic active thoracic sarcoidosis.
    Broulik PD; Votava V; Pacovsky V
    Eur Respir J; 1990 Apr; 3(4):447-9. PubMed ID: 2365038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
    Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.